BioTech 365

MARCH 12, 2021

Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. –(BUSINESS WIRE)–Amring Pharmaceuticals Inc. BERWYN, Pa.–(BUSINESS

Licensing 52

Licensing Licensing Generic Pharmaceutical Development 52

Pharma in Brief

DECEMBER 3, 2023

The original Regulations came into force on March 12, 1993, alongside changes to the Patent Act that abolished compulsory licenses for medicines and created an early-working exception to patent infringement. Further information We provide updates on the Regulations and other industry developments here at Pharma in Brief.

Regulation 52

Regulation Compliance Medicine Manufacturing 52

XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Pfizer Inc.

Sales 91

Sales Manufacturing FDA Approval Life Science 91

The Pharma Data

DECEMBER 23, 2020

Agreement leverages Aurobindo’s existing development, commercial and manufacturing infrastructure. Commenting on the development, Mr. N. Aurobindo Pharma and COVAXX are partnering on clinical development, manufacturing and marketing of COVAXX’s vaccine candidate, UB-612. ” .

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

The Pharma Data

DECEMBER 23, 2020

company developing UB-612 a multitope peptide-based vaccine to fight COVID-19, today announced an exclusive agreement with Aurobindo Pharma to expand its global development and commercialization of UB-612 to India and the United Nations Children’s Fund (UNICEF) agency. Commenting on the development, Mr. N. HAUPPAUGE, N.Y.–(

Vaccination 52

Vaccination Vaccine Manufacturing Antibody 52